Clinical trials
Post Acute Sequelae of COVID-19 clinical trials
Below are recruiting post acute sequelae of covid-19 clinical trials, each written for real people, not researchers. We’re tracking 24 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07781501Recruiting
Study of long-term effects of covid-19
This study looks at the long-term effects of COVID-19, sometimes called Long COVID. By studying saliva and health info, researchers hope to understand why some people have lasting symptoms.
Chapel Hill, North CarolinaAges 18–75 - NCT05566483Recruiting
Study long COVID physiology and cardiopulmonary rehab effects
This study looks at how long COVID affects the body and whether cardiopulmonary rehabilitation improves quality of life and physical function. It may help participants better understand their symptoms and see if a structured rehab program improves daily abilities.
Aurora, ColoradoAges 18 years+ - NCT05866952Recruiting
Breathing and blood-flow testing in long-COVID symptoms
This trial studies how the lungs’ breathing (airflow) and blood flow may be off in people with long-COVID symptoms like tiredness, shortness of breath, or trouble exercising. It may help researchers understand what’s driving symptoms and what kinds of abnormalities could be targeted.
Boston, MassachusettsAges 18–99 - NCT06006884Recruiting
Understanding long-term lung effects after COVID-19
This study looks at why some people develop long-term lung problems after COVID-19. It compares people who had severe COVID-19 and were hospitalized to those who had mild infections and recovered at home.
Rochester, MinnesotaAges 18 years+ - NCT06045338Recruiting
Mind-body program for long COVID symptoms
This trial tests a mind-body intervention to help people with ongoing long COVID symptoms like pain, fatigue, or brain fog. If you've had COVID-19 and have had symptoms at least 3 days a week for 3 months, this study might help.
Boston, MassachusettsAges 18–65 - NCT06191302Recruiting
Long COVID study in Denmark
This study follows people who were hospitalized for COVID-19 to learn more about long-term health effects (post-COVID conditions). It uses blood samples already collected during their hospital stay.
HvidovreAges 18 years+ - NCT06291870Recruiting
Predicting long-term effects after COVID-19
This study looks at what happens to your thinking and daily health after COVID-19, especially if you have sleep apnea. It aims to find out who is more likely to have ongoing problems.
Detroit, MichiganAges 18 years+ - NCT06452095Recruiting
Hyperbaric oxygen therapy for long COVID brain fog
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) helps with long COVID symptoms, especially brain fog and thinking problems. It may be an option if you have had lingering symptoms for at least 2 months and can travel to one of the study sites.
Toronto, OntarioAges 18 years+ - NCT06577467Recruiting
Studying leftover virus after covid recovery
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
Bethesda, MarylandAges 18–110 - NCT06792214RecruitingPhase 4
Testing if antivirals prevent long-term heart problems after COVID-19
This study tests whether two antiviral medications, Paxlovid and Veklury (remdesivir), can reduce the risk of long-term heart and blood vessel problems after a COVID-19 infection. It is for adults recently hospitalized with COVID-19 who are not currently on oxygen therapy.
Kingston, OntarioAges 18 years+ - NCT06850350Recruiting
Long COVID and Thinking & Walking
This study looks at how Long COVID affects thinking and movement skills. If you had COVID-19 more than 3 months ago and could walk before you got sick, you may be able to help researchers understand these lasting symptoms.
Chicago, IllinoisAges 18 years+ - NCT06879925Recruiting
Qi-Gong therapy for long COVID recovery
This study tests whether gentle Qi-Gong exercises can improve physical health and quality of life for people with lingering COVID-19 symptoms (long COVID). It may help if you're over 20 and struggling with post-COVID issues.
New Taipei CityAges 20–100 - NCT06883513Recruiting
Osteopathic therapy for long COVID symptoms
This trial tests if gentle hands-on treatment (osteopathic manipulative therapy) can help relieve long-lasting COVID symptoms like fatigue, brain fog, and body pain.
Louisville, KentuckyAges 18 years+ - NCT06920628RecruitingPhase 1
Brain scan study for long COVID neurological symptoms
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
Bethesda, MarylandAges 18–70 - NCT06928506Recruiting
Study of Hi-OxSR for Long COVID treatment
This study tests whether a treatment called Hi-OxSR can help with lingering symptoms of Long COVID, especially problems with thinking and memory. You may be eligible if you've had COVID-19 at least 3 months ago and still have ongoing symptoms that affect your thinking.
Edmonton, AlbertaAges 18 years+ - NCT06940609RecruitingPhase 2
Brain scan study for Long COVID brain fog
This trial studies if brain scans can help understand 'brain fog' in Long COVID. It also looks at how a gentle magnetic stimulation might affect symptoms. If you have ongoing thinking problems after COVID, this study may help find new ways to help.
Albuquerque, New MexicoAges 18–80 - NCT06960928RecruitingPhase 3
Low dose sirolimus for long COVID
This trial tests if a low dose of sirolimus, a medicine that calms the immune system, can help people with long COVID. If you have had long COVID symptoms for at least 6 months, like severe fatigue, brain fog, or chest pain, you may be able to join.
New York, New YorkAges 18 years+ - NCT07021794RecruitingPhase 2
Antibody treatment for Long COVID symptoms
This study tests whether a lab-made antibody (sipavibart) can reduce Long COVID symptoms. It is for people who developed Long COVID after a confirmed COVID infection and still have moderate to severe fatigue and other ME/CFS-like symptoms.
Fort Lauderdale, FloridaAges 18–70 - NCT07076862RecruitingEarly Phase 1
PET scan study for long COVID symptoms
This study uses a special PET scan to look at inflammation in the body of people with long COVID (symptoms lasting 3+ months after infection). The goal is to understand why symptoms persist and find better ways to help.
Sacramento, CaliforniaAges 18 years+ - NCT07278206Recruiting
Brain stimulation for long COVID fatigue and brain fog
This trial tests whether a non-invasive brain treatment called rTMS (repetitive transcranial magnetic stimulation) can help with the severe fatigue and brain fog that often come with long COVID. You would need to be able to come to the hospital for multiple treatment sessions.
AmsterdamAges 18 years+ - NCT05131594Enrolling by invitation
Study immune response in Long COVID patients
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
Pasadena, CaliforniaAges 18 years+ - NCT05350774Enrolling by invitationPhase 2
IV immunotherapy for lingering neurologic effects after COVID-19
This Phase 2 trial tests whether intravenous immunotherapy (IVIG) can improve ongoing neurologic symptoms after a mild-to-moderate COVID-19 illness. It targets people with persistent symptoms such as brain fog, fatigue, trouble thinking, dizziness when standing, and balance or other neurologic problems.
Bethesda, MarylandAges 18–100 - NCT06679140RecruitingPhase 3
Study of Ibuzatrelvir for COVID-19 in high-risk patients
This trial tests if a new medicine called ibuzatrelvir can help people with COVID-19 who have certain health risks avoid severe illness. It is for patients who cannot or choose not to take another COVID-19 pill called Paxlovid.
Little Rock, ArkansasAges 12 years+ - NCT07256795Enrolling by invitation
ME/CFS after COVID-19 vs. before the pandemic
This study looks at how the brain's protective barrier and immune system work in people with ME/CFS, comparing those who got sick before the COVID-19 pandemic to those who developed ME/CFS after a COVID-19 infection. It aims to understand why some people have lasting brain fog, fatigue, and other neuropsychiatric symptoms.
Baltimore, MarylandAges 18–70
Hear when a new Post Acute Sequelae of COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for post acute sequelae of covid-19?
- Yes. Clin2 currently lists 24 recruiting post acute sequelae of covid-19 studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a post acute sequelae of covid-19 trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a post acute sequelae of covid-19 trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.